Power Law company profile

Abogen Biosciences

Biotech & Life Sciences · Suzhou Shi, China · Founded 2019 Unicorn

A discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

18 investors on Abogen Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Hillhouse Capital

SDIC Venture Capital

Kanghua Biological

Series B+ 15 investors entered at this stage

Ming Bioventures

Loyal Valley Capital

5Y Capital

Temasek

Boyu Capital

SoftBank

YunFeng Capital

TF Capital

Lilly Asia Ventures

GL Ventures

Invesco

PICC Capital

LYFE Capital

Highlight Capital

SoftBank Vision Fund

Global footprint

Where Abogen Biosciences has talent and traffic

Workforce by country

5 countries with
team presence

🇨🇳 China85.2%

🇺🇸 United States8.6%

🇳🇱 Netherlands2.1%

🇭🇰 Hong Kong2.1%

🇵🇭 Philippines2.1%

5 countries shown

Web traffic by country

2.7K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Patent intelligence

$7M patent portfolio · 49 active families

Estimated portfolio value

$7M

0.37% of valuation · 118.1× smaller than top peer BioNTech ($780M)

49 active patent families

Where Abogen Biosciences innovates Molecular biologyNanoparticleNucleic acid moleculeTGE VACCINENucleic Acid Vaccines

Where Abogen Biosciences concentrates vs peers

Each axis is a top-10 topic across Abogen Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Abogen Biosciences

An AI-synthesized read of the highest-engagement posts about Abogen Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Abogen Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles